FTC Imposes Conditions on Danaher Corporation’s Acquisition of GE Biopharma
Date
Danaher Corporation has agreed to divest assets to settle Federal Trade Commission charges that its proposed $21.4 billion acquisition of General Electric’s biopharmaceutical business, GE Biopharma...